Evidence map›Paper›PMID 40895451›Full record

ArticleJournal of clinical and translational science2025

Exploring barriers, needs, and facilitators for clinical and translational research in Oklahoma: A sequential mixed-methods study.

Motolani E Ogunsanya, Laura A Beebe, Janis E Campbell, Nicole Holmes, Timothy VanWagoner, Judith James

Abstract read
In one paragraph

Article in Journal of clinical and translational science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Motolani E OgunsanyaDepartment of Family and Preventive Medicine, University of Oklahoma Health Sciences, Oklahoma City, OK, USA.ORCID https://orcid.org/0000-0002-4005-0446
Laura A BeebeDepartment of Biostatistics and Epidemiology, University of Oklahoma Health Sciences, Oklahoma City, OK, USA.
Janis E CampbellDepartment of Biostatistics and Epidemiology, University of Oklahoma Health Sciences, Oklahoma City, OK, USA.ORCID https://orcid.org/0000-0001-9577-9122
Nicole HolmesOklahoma Clinical & Translational Science Institute and Department of Medicine, University of Oklahoma Health Sciences, Oklahoma City, OK, USA.
Timothy VanWagonerOklahoma Clinical & Translational Science Institute and Department of Medicine, University of Oklahoma Health Sciences, Oklahoma City, OK, USA.
Judith JamesOklahoma Clinical & Translational Science Institute and Department of Medicine, University of Oklahoma Health Sciences, Oklahoma City, OK, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Clinical and translational research (CTR) plays a vital role in improving health outcomes, but its success relies heavily on institutional support, infrastructure, and workforce capacity. This study aimed to explore the barriers, needs, and facilitators to conducting CTR in Oklahoma, highlighting both the strengths and gaps within the research ecosystem. Methods: A sequential, descriptive mixed-methods design was employed, combining survey data ( Results: Key barriers included lack of protected research time (23.9%), limited pilot funding (15.3%), and administrative hurdles such as IRB delays. Researchers expressed a strong need for centralized tools to support networking, scientific writing, and data access. Qualitative findings revealed additional needs, such as bridge funding and mentorship, not fully captured in the survey. Facilitators included Oklahoma Shared Clinical and Translational Resources (OSCTR)-supported professional development and mentoring programs, though participants noted a heavy reliance on OSCTR as the primary support source, with few decentralized alternatives. Conclusions: While CTR infrastructure in Oklahoma has expanded, critical gaps remain in mentorship, data access, and institutional support. To build a more resilient and inclusive research environment, stakeholders should consider investing in decentralized systems, bridge funding, structured mentorship, and collaborative tools tailored to the state's rural, tribal, and academic diversity. These findings may inform policy and strategic planning in Oklahoma and other underserved regions aiming to strengthen CTR capacity.

Indexed as

barriersClinical and translational researchmixed-methods researchneeds assessmentOklahoma

Identifiers

PMID40895451
PMCPMC12392360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.